Pemphigus Market Research Report – Forecast to 2027

Global Pemphigus Market Research Report:  By Type (Pemphigus Vulgaris and Others), by Diagnosis (Skin Peeling, Endoscopy, and Others), by Treatment (Corticosteroid, Biological Therapies, and Others), by End-Users (Hospitals and Others)– Forecast Till 2027

ID: MRFR/Pharma/5024-HCR | | Region: Global | 100 pages

Market Scenario


The global pemphigus market is expected to grow significantly over the forecast period. It is estimated that the global pemphigus market is expected to register a CAGR of ~ 45% during the forecast period from 2018 to 2023.


Pemphigus is an autoimmune disorder. It is a group of rare skin disorders that cause blisters, sores on the skin, in the mouth, or on the genitals. In pemphigus immune system mistakenly produces antibodies that kill healthy cells in the skin and mucous membrane. Sometimes it may develop as a side effect of medication by consuming drugs of certain blood pressure. 


Numerous factors are anticipated to drive the growth of this market such as increasing prevalence of cancer, consumption of tobacco, unhealthy lifestyle, increasing pollution, increasing geriatric population and increasing awareness for oral hygiene. According to the international pemphigus and pemphigoid foundation, approximately 2,500 people in the US were suffering from pemphigus disorder. And worldwide incidences of pemphigus were found to be 40,000 to 50,000 in 2017.


Despite the drivers, factors such as rising healthcare expenditure, increasing number of research and development, unfavorable reimbursement scenario and stringent regulatory policies may hamper the growth of the market during the assessment period.


Segmentation


The global pemphigus market has been segmented into types, diagnosis, treatment, and end users. Based on types of pemphigus the market is further segmented into pemphigus vulgaris, pemphigus foliaceus, pemphigus vegetans, paraneoplastic pemphigus.


The market on the basis of diagnosis has been segmented into skin peeling, skin biopsy, run blood tests, endoscopy.


The market, by treatment, has been segmented corticosteroids, initial therapy, maintenance therapy


immunosuppressants, biological therapies, intravenous immunoglobulin (IVIG) therapy, other medication.


Based on end-user market is segmented into hospitals and clinics, laboratories, academic and research institutes.


Key players


Some of the key players in the global pemphigus market are Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma, Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, GlaxoSmithKline LLC, Teva Pharmaceutical Industries.


Regional Market Summary


Global Pemphigus Market Share (%), by Region, 2018


Pemphigus Market Share


Source: Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC)


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pemphigus market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European pemphigus market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The pemphigus market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pemphigus market in the Middle East & Africa has been segmented into the Middle East and Africa.


Geographically, the Americas is anticipated to dominate the global pemphigus market. The market growth in this region is attributed to the increasing geriatric population with pemphigus disorder, investment in research and development and technological advancement. According to the US National Institute of Health 32 cases per million population were reported for pemphigus incidences in the US.


Europe is expected to be the second largest market in the globe owing to the increasing number of geriatric populations, increasing government expenditure for oral hygiene, the presence of disposable income and increasing of tobacco in this region. According to the data by the Europe PMC, in 2017, incidences of pemphigus ranging from 0.5 cases per million population in Germany to 8 cases per million population in Greece reported incidences are 1.6,16.1.


Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of pemphigus, and oral related problems in the developing countries, increasing disposable income and growing healthcare expenditure.


The Middle East and Africa is expected to account for the lowest market share in the global pemphigus market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.


Global Pemphigus Market, by Pemphigus Types



  • Pemphigus Vulgaris

  • Pemphigus Foliaceus

  • Pemphigus Vegetans

  • Paraneoplastic Pemphigus


Global Pemphigus Market, by Diagnosis



  • Skin peeling

  • Skin biopsy

  • Run blood tests

  • Endoscopy


Global Pemphigus Market, by Treatment



  • Initial therapy

  • Maintenance therapy

  • Immunosuppressants

  • Biological therapies

  • Intravenous Immunoglobulin (IVIG) therapy

  • Other medication


Global Pemphigus Market, by End User



  • Laboratories

  • Hospitals and Clinics

  • Academic and Research Institutes


Global Pemphigus Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific



  • Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Hospitals and clinics

  • Laboratories and associations

  • Healthcare providers

  • Research institutes and academic centers

  • Government associations

  • Market research and consulting



Frequently Asked Questions (FAQ) :


Pemphigus is a group of rare autoimmune skin disorders that cause blisters, sores on the skin, in the mouth, or on the genitals.

The market is expected to exhibit a strong 45% CAGR over the forecast period from 2020-2027.

The increasing prevalence of cancer is likely to be a major driver for the Pemphigus Market over the forecast period.

Americas are anticipated to dominate the global Pemphigus Market.

Leading players in the market include Novartis, Principia Biopharma, and Pfizer, among others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Pemphigus Market, by Pemphigus Types

6.1 Introduction

6.2 Pemphigus Vulgaris

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Pemphigus Foliaceus

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Pemphigus Vegetans

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Paraneoplastic Pemphigus

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Pemphigus Market, by Diagnosis

7.1 Introduction

7.2 Skin Peeling

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Skin Biopsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Run Blood Tests

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Endoscopy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Pemphigus Market, by Treatment

8.1 Introduction

8.2 Corticosteroids

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Initial Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Maintenance Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.5 Immunosuppressants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.6 Biological Therapies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.7 Intravenous Immunoglobulin (IVIG) Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.8 Other medication

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Pemphigus Market, by End User

9.1 Introduction

9.2 Laboratories

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4 Academic and Research Institutes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 10. Global Pemphigus Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Novartis Pharmaceuticals

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Hoffmann-La Roche

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Principia Biopharma, Inc

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Argenx

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Sanofi S.A.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Pfizer Inc

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Teligent Inc

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 GlaxoSmithKline LLC

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Teva Pharmaceutical Industries

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Pemphigus Industry

Chapter 14. Appendix


LIST OF TABLES

Table 1 Global Pemphigus Market Synopsis, 2020–2027

Table 2 Global Pemphigus Market Estimates and Forecast, 2020–2027

(USD Million)

Table 3 Global Pemphigus Market, by Region, 2020–2027 (USD Million)

Table 4 Global Pemphigus Market, by Pemphigus Types, 2020–2027 (USD Million)

Table 5 Global Pemphigus Market, by Diagnosis, 2020–2027(USD Million)

Table 6 Global Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 7 Global Pemphigus Market, by End User, 2020–2027 (USD Million)

Table 8 North America: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD

Million)

Table 9 North America: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 10 North America: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 11 North America: Pemphigus Market, by End-User, 2020–2027 (USD Million)

Table 12 US: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD Million)

Table 13 US: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 14 US: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 15 US: Pemphigus Market, by End User, 2020–2027 (USD Million)

Table 16 Canada: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD Million)

Table 17 Canada: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 18 Canada: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 19 Canada: Pemphigus Market, by End-User, 2020–2027 (USD Million)

Table 20 South America: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD

Million)

Table 21 South America: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 22 South America: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 23 South America: Pemphigus Market, by End-User, 2020–2027 (USD Million)

Table 24 Europe: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD Million)

Table 25 Europe: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 26 Europe: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 27 Europe: Pemphigus Market, by End-User, 2020–2027 (USD Million)

Table 28 Western Europe: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD

Million)

Table 29 Western Europe: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 30 Western Europe: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 31 Western Europe: Pemphigus Market, by End-User, 2020–2027 (USD Million)

Table 32 Eastern Europe: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD

Million)

Table 33 Eastern Europe: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 34 Eastern Europe: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 35 Eastern Europe: Pemphigus Market, by End-User, 2020–2027(USD Million)

Table 36 Asia-Pacific: Pemphigus Market, by Pemphigus Types, 2020–2027 (USD

Million)

Table 37 Asia-Pacific: Pemphigus Market, by Diagnosis, 2020–2027 (USD Million)

Table 38 Asia-Pacific: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 39 Asia-Pacific: Pemphigus Market, by End-User, 2020–2027 (USD Million)

Table 40 Middle East & Africa: Pemphigus Market, by Pemphigus Types, 2020–2027

(USD Million)

Table 41 Middle East & Africa: Pemphigus Market, by Technology, 2020–2027 (USD Million)

Table 42 Middle East & Africa: Pemphigus Market, by Treatment, 2020–2027 (USD Million)

Table 43 Middle East & Africa: Pemphigus Market, by End-User, 2020–2027 (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Pemphigus Market

Figure 3 Segmentation Market Dynamics for Global Pemphigus Market

Figure 4 Global Pemphigus Market Share, By Pemphigus Types, 2020

Figure 5 Global Pemphigus Market Share, By Diagnosis, 2020

Figure 6 Global Pemphigus Market Share, By Treatment, 2020

Figure 7 Global Pemphigus Market Share, By End User, 2020

Figure 8 Global Pemphigus Market Share, By Region, 2020

Figure 9 North America: Pemphigus Market Share, By Country, 2020

Figure 10 Europe: Pemphigus Market Share, By Country, 2020

Figure 11 Asia-Pacific: Pemphigus Market Share, By Country, 2020

Figure 12 Middle East & Africa: Pemphigus Market Share, By Country, 2020

Figure 13 Global Pemphigus Market: Company Share Analysis, 2020 (%)

Figure 14 Novartis Pharmaceuticals.: Key Financials

Figure 15 Novartis Pharmaceuticals.: Segmental Revenue

Figure 16 Novartis Pharmaceuticals.: Geographical Revenue

Figure 17 Hoffmann-La Roche.: Key Financials

Figure 18 Hoffmann-La Roche.: Segmental Revenue

Figure 19 Hoffmann-La Roche.: Geographical Revenue

Figure 20 Principia Biopharma, Inc.: Key Financials

Figure 21 Principia Biopharma, Inc.: Segmental Revenue

Figure 22 Principia Biopharma, Inc.: Geographical Revenue

Figure 23 Argenx: Key Financials

Figure 24 Argenx: Segmental Revenue

Figure 25 Argenx: Geographical Revenue

Figure 26 Sanofi S.A.: Key Financials

Figure 27 Sanofi S.A.: Segmental Revenue

Figure 28 Sanofi S.A.: Geographical Revenue

Figure 29 Pfizer Inc: Key Financials

Figure 30 Pfizer Inc: Segmental Revenue

Figure 31 Pfizer Inc: Geographical Revenue

Figure 32 Teligent Inc: Key Financials

Figure 33 Teligent Inc: Segmental Revenue

Figure 34 Teligent Inc: Geographical Revenue

Figure 35 GlaxoSmithKline LLC: Key Financials

Figure 36 GlaxoSmithKline LLC: Segmental Revenue

Figure 37 GlaxoSmithKline LLC: Geographical Revenue

Figure 38 Teva Pharmaceutical Industries.: Key Financials

Figure 39 Teva Pharmaceutical Industries.: Segmental Revenue

Figure 40 Teva Pharmaceutical Industries.: Geographical Revenue